The present invention provides for monoclonal anti-IFITM2 and anti-IFITM3 antibodies or a fragment thereof, pharmaceutical compositions comprising said antibodies and its use in the treatment of viral infections, preferably of SARS-CoV-2 infection in host human cells.
"Monoclonal antibodies for the treatment of viral infections”
Maria Caterina Turco;Liberato Marzullo;Margot De Marco;Anna BASILE;Gianluigi FRANCI;
2021-01-01
Abstract
The present invention provides for monoclonal anti-IFITM2 and anti-IFITM3 antibodies or a fragment thereof, pharmaceutical compositions comprising said antibodies and its use in the treatment of viral infections, preferably of SARS-CoV-2 infection in host human cells.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
